Abstract

Indoramin (Baratol - Wyeth) has been recently introduced for the treatment of all grades of essential hypertension. The manufacturer claims that it causes arteriolar dilatation without a compensatory tachycardia and is without risk of exacerbating bronchospasm or the symptoms of peripheral vascular disease.